Genesis Healthcare, Inc. (NYSE:GEN) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On April 7, 2017, Steven Fishman notified the Company’s Board of Directors (the “Board”) of his decision to resign from the Board effective immediately. Mr. Fishman’s resignation is for health and personal reasons and was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. Mr. Fishman had been serving as Chairman of the Board.
On April 7, 2017, the Board appointed Robert Fish, a current Board member, as Chairman of the Board. In appointing Mr. Fish as Chairman, the Board recognized Mr. Fish’s extensive knowledge and experience in the healthcare industry, including his role as chief executive officer of the Company’s predecessor and a number of other healthcare companies.
About Genesis Healthcare, Inc. (NYSE:GEN)
Genesis Healthcare, Inc., formerly Skilled Healthcare Group, Inc., is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services, including physician services and other healthcare related services. It offers inpatient services through its network of over 500 skilled nursing and assisted/senior living facilities in 34 states, consisting of over 475 skilled nursing facilities and over 35 stand-alone assisted/senior living facilities. Its skilled nursing and assisted/senior living facilities have over 61,000 licensed beds, with its states of operation in California, Maryland, Massachusetts, New Jersey, and Pennsylvania. Genesis Healthcare, Inc. (NYSE:GEN) Recent Trading Information
Genesis Healthcare, Inc. (NYSE:GEN) closed its last trading session down -0.10 at 2.43 with 114,860 shares trading hands.